| Study Period | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Enrollment | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Week | 0 | 2 | 4 | 6 | 8 | Third trimester | Delivery | 6Â weeks post-partum | 3Â months post-partum | 6Â months post-partum |
Enrollment: | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Eligibility Screen | X |  |  |  |  |  |  |  |  |  |
 Informed consent | X |  |  |  |  |  |  |  |  |  |
 Socio-demographic questions | X |  |  |  |  |  |  |  |  |  |
Assessments: | X | Â | Â | Â | X | Â | Â | Â | Â | Â |
 HFIASa, Food frequency questionnaire | X |  |  |  | X |  |  |  |  |  |
 Clinic visit for intervention and control food supply | X | X | X | X | X |  |  |  |  |  |
 Adherence/educational messages | X | X | X | X | X |  |  |  |  |  |
 Surveillance of clinical events | X | X | X | X | X |  |  |  |  |  |
 Maternal anthropometric measurements | X | X | X | X | X |  |  |  |  |  |
 Infant anthropometric measurements |  |  |  |  |  |  | X | X | X | X |
Interventions: | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 Food distribution | X | X | X | X | X | X |  |  |  |  |
 Bed net distribution | X |  |  |  |  |  |  |  |  |  |
 Testing and treatment of bacterial vaginosis | X |  |  |  |  | X |  |  |  |  |
 Albendazole (400 mg) | X |  |  |  |  |  |  |  |  |  |
 Azithromycin (1 g) | X |  |  |  |  | X |  |  |  |  |
 Sulfadoxine/ pyrimethamine (1500 mg/75 mg) | X |  | X |  | X | X |  |  |  |  |